Garivulimab (Anti-B7-H1 / PD-L1 / CD274)
Product Specifications
CAS Number
2342597-81-1
Synonyms
BGB-A333
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Garivulimab (Anti-B7-H1 / PD-L1 / CD274) is a humanized immunoglobulin G1 (IgG1) -variant monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 144.3 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940218-500 1x 500 µL
CD100 (Semaphorin-4D) (A8), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741429-100 1x 100 µL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681820-100 1x 100 µL
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681731-500 1x 500 µL
Chromogranin A / CHGA (Neuroendocrine Marker) (CHGA/1731R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401778-500 1x 500 µL
Spectrin beta III (SPTBN2) (SPTBN2/1778), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC061099-500 1x 500 µL
CD31 / PECAM-1 (C31.3 + C31.7 + C31.10), CF405L conjugate, 0.1mg/mL
Sign In for Pricing
View Details